- Preface
- List of abbreviations
- Chapter 1 Mechanisms of action and resistance to modern antibacterials, with a history of their development
- Chapter 2 Inhibitors of bacterial cell wall synthesis
- Chapter 3 Inhibitors of bacterial protein synthesis
- Chapter 4 Synthetic antibacterial agents and miscellaneous antibiotics
- Chapter 5 Antiviral agents
- Chapter 6 Antiretroviral agents
- Chapter 7 Drugs used in the treatment of viral hepatitis
- Chapter 8 Antifungal agents
- Chapter 9 Antiprotozoal and anthelminthic agents
- Chapter 10 The problem of resistance
- Chapter 11 The genetics and mechanisms of acquired resistance
- Chapter 12 Laboratory investigations and the treatment of infection
- Chapter 13 General principles of the treatment of infection
- Chapter 14 Pharmacokinetic and pharmacodynamic principles
- Chapter 15 Prescribing in special groups: effects of age, pregnancy, body weight, and hepatic and renal impairment
- Chapter 16 OPAT: outpatient parenteral antimicrobial therapy
- Chapter 17 Adverse drug reactions, and patient safety
- Chapter 18 Chemoprophylaxis and immunization
- Chapter 19 Guidelines, formularies, and antimicrobial policies
- Chapter 20 Antimicrobial stewardship, surveillance of antimicrobial consumption, and its consequences
- Chapter 21 Respiratory tract infections
- Chapter 22 Topical use of antimicrobial agents
- Chapter 23 Urinary tract infections
- Chapter 24 Sexually transmitted infections
- Chapter 25 Gastrointestinal infections
- Chapter 26 Serious bacterial bloodstream infections
- Chapter 27 Bone and joint infections
- Chapter 28 Infections of the central nervous system
- Chapter 29 Skin and soft-tissue infections
- Chapter 30 Tuberculosis and other mycobacterial diseases
- Chapter 31 Infections in immunocompromised patients, including HIV/AIDS
- Chapter 32 Viral infections
- Chapter 33 Management of HIV infection
- Chapter 34 Treatment of chronic viral hepatitis
- Chapter 35 Parasitic disease
- Chapter 36 The development and marketing of antimicrobial drugs
- Appendix: Recommendations for Further Reading
- Index
(p. 121) Laboratory investigations and the treatment of infection
- Chapter:
- (p. 121) Laboratory investigations and the treatment of infection
- Author(s):
Peter Davey
, Mark Wilcox
, William Irving
, and Guy Thwaites
- DOI:
- 10.1093/med/9780199689774.003.0012
This chapter covers the basic principles of using a microbiology laboratory to guide the investigation and treatment of infections. The importance of the requestor providing sufficient clinical details is emphasized, as this can affect not only which tests are performed but also how results are reported. Key issues are discussed about the way in which specimens are collected, and transport can markedly affect the end result of investigations. The main techniques for growing or detecting the presence of microorganisms are reviewed, including the rapid expansion in use of PCR-based tests. Finally, the way in which antimicrobial susceptibility is determined and then reported is discussed.
Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.
Please subscribe or login to access full text content.
If you have purchased a print title that contains an access token, please see the token for information about how to register your code.
For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.
- Preface
- List of abbreviations
- Chapter 1 Mechanisms of action and resistance to modern antibacterials, with a history of their development
- Chapter 2 Inhibitors of bacterial cell wall synthesis
- Chapter 3 Inhibitors of bacterial protein synthesis
- Chapter 4 Synthetic antibacterial agents and miscellaneous antibiotics
- Chapter 5 Antiviral agents
- Chapter 6 Antiretroviral agents
- Chapter 7 Drugs used in the treatment of viral hepatitis
- Chapter 8 Antifungal agents
- Chapter 9 Antiprotozoal and anthelminthic agents
- Chapter 10 The problem of resistance
- Chapter 11 The genetics and mechanisms of acquired resistance
- Chapter 12 Laboratory investigations and the treatment of infection
- Chapter 13 General principles of the treatment of infection
- Chapter 14 Pharmacokinetic and pharmacodynamic principles
- Chapter 15 Prescribing in special groups: effects of age, pregnancy, body weight, and hepatic and renal impairment
- Chapter 16 OPAT: outpatient parenteral antimicrobial therapy
- Chapter 17 Adverse drug reactions, and patient safety
- Chapter 18 Chemoprophylaxis and immunization
- Chapter 19 Guidelines, formularies, and antimicrobial policies
- Chapter 20 Antimicrobial stewardship, surveillance of antimicrobial consumption, and its consequences
- Chapter 21 Respiratory tract infections
- Chapter 22 Topical use of antimicrobial agents
- Chapter 23 Urinary tract infections
- Chapter 24 Sexually transmitted infections
- Chapter 25 Gastrointestinal infections
- Chapter 26 Serious bacterial bloodstream infections
- Chapter 27 Bone and joint infections
- Chapter 28 Infections of the central nervous system
- Chapter 29 Skin and soft-tissue infections
- Chapter 30 Tuberculosis and other mycobacterial diseases
- Chapter 31 Infections in immunocompromised patients, including HIV/AIDS
- Chapter 32 Viral infections
- Chapter 33 Management of HIV infection
- Chapter 34 Treatment of chronic viral hepatitis
- Chapter 35 Parasitic disease
- Chapter 36 The development and marketing of antimicrobial drugs
- Appendix: Recommendations for Further Reading
- Index